Not only does Sweden have a thriving economy that largely depends on manufacturing and exports, but it also has a thriving life sciences sector. 🌟 In fact, did you know that, in 2020, the country’s life sciences sector recorded a net turnover of almost SEK 365 billion ($34 billion)? 💰 This marks an impressive increase of just over SEK 158 billion ($14.8 billion) since 2014. 📈 Read our latest article, as we take a look at eight Swedish companies spearheading the growth of the country’s biotech scene! 🔬🇸🇪 https://lnkd.in/dkMQYQUw #swedishbiotech #lifesciences #biotech #innovation #healthcare #economicgrowth #biotechindustry #manufacturing #biotechnews #pharma #biotechcompanies #swedisheconomy Amferia | Anocca | Aprea Therapeutics | Asgard Therapeutics | BioInvent International AB | Diamyd Medical | Hamlet BioPharma | Modus Therapeutics Holding AB
Labiotech.eu’s Post
More Relevant Posts
-
In an evolving biotech landscape, companies face critical choices about their manufacturing approaches, where quality, scalability, and cost considerations intersect. https://lnkd.in/eCwVUPW6 In this exclusive interview with Dr. Ulrich Rümenapp, Senior Biotech Program Lead at Bayer, he shares his insights on making informed, future-proof decisions for manufacturing in the biotech sector. Read the full interview here: https://lnkd.in/eCwVUPW6 #pharma #biotech #partnerships
-
-
🧬 Breakthrough in Oligonucleotide Manufacturing! 💊 Discover how Biogen, the company behind the groundbreaking ALS drug Qalsody, is revolutionizing antisense oligonucleotide (ASO) production. Learn about: ✨ The game-changing role of ultrafiltration and diafiltration ✨ Achieving higher concentrations and better yields ✨ Overcoming common manufacturing challenges 📖 Want to stay ahead in biopharma innovation? This article by Gareth Macdonald is a must-read for industry professionals and science enthusiasts alike! https://lnkd.in/eGs_cvRB #Biopharma #DrugManufacturing #Innovation #ASOTechnology"
-
-
The latest EarthRate ESG Pharma and Biotech weekly (5.4.2024): - new Covid - cases at low levels in Europe - Q1 2024 Covid deaths in the US over 23.000 - Novo Nordisk and Nvidia to build AI supercomputer in Denmark - new healthcare listing in the US : Solventum in Nyse - most pharma stocks declined during the week's period Read the report here: www.pubplus.club #earthrate,#esginvesting #pharma #biotech
-
Successful drug launches are built on solid strategy and precise execution. Don’t miss our last session in the Better Biotech Growth series to learn essential steps for commercial excellence and how to position your drug for long-term success. Register now: skp.link/bj9u #BetterBiotechGrowth #Biotech #CommercialExcellence #InnovationToMarket #SimonKucher
-
-
🔑 Set Your Partnerships Up for Success in 2025. As the year comes to a close, it’s time to prepare for a strong start to 2025. Proactive planning ensures your partnerships are aligned, timelines are on track, and everyone is ready to hit the ground running. ➡️ Here are key steps to consider: #Biotechnology #Pharma #PartnershipSuccess #StrategicPlanning #AllianceManagement #Collaboration
-
-
SFBN Feed: After ALS flop, Amylyx bought a GLP-1 drug from bankrupt Eiger. Here’s how that fits into its plans https://lnkd.in/gTshGi5Q Amylyx pulled its ALS drug from the market earlier this year after a Phase III trial failure. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #BayArea #SanFrancisco #Biotech #Lifescience #News
-
Successful drug launches are built on solid strategy and precise execution. Don’t miss our last session in the Better Biotech Growth series to learn essential steps for commercial excellence and how to position your drug for long-term success. Register now: skp.link/bj9u #BetterBiotechGrowth #Biotech #CommercialExcellence #InnovationToMarket #SimonKucher
-
-
"How to handle biomanufacturing?" 📢 This important question was answered by Dr Adriana Kiędzierska - Mencfeld, our Chief Integration Officer, at CEBioForum 2024 conference. Adriana shared her knowledge and extensive experience in #biomanufacturing during today's discussion panel. 🎤 "Development of biosimilar drugs is an very expensive and time-consuming process. A company's market advantage will be determined by its ability to delivery product to the market with proper COGS, reflecting price erosion. We can achieve this through process intensification. Remember, when we talk about a company's market advantage, we are also talking about increasing the availability of a particular biological drug for patients. It's not just about efficiency; it's the essence of our actions”. Thank you to all who joined Adriana in this discussion! #Biotech #Pharma #Innovation #CEBioforum #Insights Central European BioForum
-
-
The BioTech sector is set to redefine healthcare with groundbreaking innovations in 2025. Here are five standout companies pushing boundaries with bold ideas and cutting-edge advancements. 🔬 Who’s on your radar for 2025? Let us know in the comments! 🚀 Anavex Life Sciences, Jazz Pharmaceuticals, Life Biosciences, Wave Life Sciences, Skye Bioscience Inc. #PrecisionMedicine #CandidateInsights #BioTech #HealthTech #BioTechCareers #KenkoTechFutures
-
➡️ The temporary freeze brought on by the COVID-19 pandemic is well and truly over, as 2023 saw a new high in the number of drugs in development. However, while there are signs the industry is continuing to grow, the forecast is decidedly mixed when looking at how many of these drugs reach later stages of development and emerge from the pipeline. #pharma #biotech #research #growth #OnlineCourses #SymmetricTraining
